JP2016536993A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536993A5
JP2016536993A5 JP2016530177A JP2016530177A JP2016536993A5 JP 2016536993 A5 JP2016536993 A5 JP 2016536993A5 JP 2016530177 A JP2016530177 A JP 2016530177A JP 2016530177 A JP2016530177 A JP 2016530177A JP 2016536993 A5 JP2016536993 A5 JP 2016536993A5
Authority
JP
Japan
Prior art keywords
coli
strain
modified
mutation
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016530177A
Other languages
English (en)
Japanese (ja)
Other versions
JP6545676B2 (ja
JP2016536993A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/065545 external-priority patent/WO2015073720A1/en
Publication of JP2016536993A publication Critical patent/JP2016536993A/ja
Publication of JP2016536993A5 publication Critical patent/JP2016536993A5/ja
Application granted granted Critical
Publication of JP6545676B2 publication Critical patent/JP6545676B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016530177A 2013-11-14 2014-11-13 改善された代謝能力を有する細菌 Active JP6545676B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361904298P 2013-11-14 2013-11-14
US61/904,298 2013-11-14
PCT/US2014/065545 WO2015073720A1 (en) 2013-11-14 2014-11-13 Bacteria with improved metabolic capacity

Publications (3)

Publication Number Publication Date
JP2016536993A JP2016536993A (ja) 2016-12-01
JP2016536993A5 true JP2016536993A5 (enExample) 2017-12-28
JP6545676B2 JP6545676B2 (ja) 2019-07-17

Family

ID=53058029

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016530177A Active JP6545676B2 (ja) 2013-11-14 2014-11-13 改善された代謝能力を有する細菌

Country Status (4)

Country Link
US (2) US9902965B2 (enExample)
EP (1) EP3068887B1 (enExample)
JP (1) JP6545676B2 (enExample)
WO (1) WO2015073720A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2981583C (en) * 2015-04-02 2022-11-15 Scarab Genomics, Llc Continuous fermentation process for production of biological product using reduced genome escherichia coli
IL261516B2 (en) 2016-03-15 2025-04-01 Apse Inc Methods and compositions for the enhanced production of double-stranded RNA
WO2019050872A1 (en) 2017-09-05 2019-03-14 Scarab Genomics, Llc METHODS AND COMPOSITIONS FOR ENHANCED EXPRESSION OF RECOMBINANT PROTEINS
CN108587992B (zh) * 2018-04-10 2022-03-15 安徽大学 一种高效分泌表达抗VEGF-Fab抗体片段的高产菌株及其构建方法
BR112021024175A2 (pt) * 2019-05-30 2022-04-12 Rnaissance Ag Llc Métodos e composições aprimorados para aumentar a produção de rna fita dupla
US20230167467A1 (en) * 2020-04-15 2023-06-01 University of Alaska Anchorage Methods and compositions for the production of isobutene
US12168679B2 (en) 2020-11-10 2024-12-17 Northwestern University Modified bacteria for enhanced bioproduction and methods of using the same
CN120882735A (zh) 2023-01-25 2025-10-31 诺韦尔生物技术美国公司 用于产品制造的表达系统

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578464A (en) 1989-10-31 1996-11-26 Schering Corporation E. coli secretory strains
US5747662A (en) 1995-03-01 1998-05-05 Genentech, Inc. Methods and compositions for secretion of heterologous polypeptides
US6022952A (en) 1998-04-01 2000-02-08 University Of Alberta Compositions and methods for protein secretion
US8119365B2 (en) 2002-01-23 2012-02-21 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US8039243B2 (en) 2002-01-23 2011-10-18 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US6989265B2 (en) 2002-01-23 2006-01-24 Wisconsin Alumni Research Foundation Bacteria with reduced genome
US7303906B2 (en) 2002-09-06 2007-12-04 Wisconsin Alumni Research Foundation Competent bacteria
US7300776B2 (en) * 2004-04-26 2007-11-27 Ajinomoto Co., Inc. L-amino acid-producing bacterium and a method for producing L-amino acid
AU2005308101A1 (en) * 2004-11-26 2006-06-01 Kyowa Hakko Kirin Co., Ltd. Industrially useful microorganism
CA2626900C (en) 2005-08-20 2013-07-23 Scarab Genomics, Llc Reduced genome e. coli
JP2009165355A (ja) 2006-04-28 2009-07-30 Ajinomoto Co Inc Ｌ−アミノ酸を生産する微生物及びｌ−アミノ酸の製造法
WO2007140816A1 (en) * 2006-06-09 2007-12-13 Metabolic Explorer Glycolic acid production by fermentation from renewable resources
EP2254994B1 (en) * 2008-02-22 2015-05-20 Scarab Genomics, LLC Compositions and methods for amino acid biosynthesis
US20110111458A1 (en) * 2008-03-18 2011-05-12 Kyowa Hakko Kirin Co., Ltd. Industrially useful microorganism
US20130210097A1 (en) * 2010-08-27 2013-08-15 Metabolic Explorer Glycolic acid fermentative production with a modified microorganism
EP2768943B1 (en) 2011-10-20 2017-06-21 Scarab Genomics LLC Reduced genome bacteria with improved genetic stability
JP6473460B2 (ja) * 2014-03-03 2019-02-20 スカラブ ゲノミクス， エルエルシー 大腸菌における組換えｃｒｍ１９７の産生強化

Similar Documents

Publication Publication Date Title
JP2016536993A5 (enExample)
PH12018550020A1 (en) Production of human milk oligosaccharides in microbial hosts with engineered import/export
CY1123815T1 (el) Υποκατεστημενες ινδαζολες, διαδικασια για την παρασκευη τους, φαρμακευτικα παρασκευασματα, τα οποια τις περιεχουν, καθως και η χρηση τους για την παρασκευη φαρμακευτικων μεσων
JP2014525395A5 (enExample)
CY1120493T1 (el) Πρωτεϊνη συντηξης που περιλαμβανει ιντερλευκινη 4 και ιντερλευκινη 10
ZA202001294B (en) Multispecific antibody
Piñero-Lambea et al. Mycoplasma pneumoniae genome editing based on oligo recombineering and Cas9-mediated counterselection
JP2014530625A5 (enExample)
MX344314B (es) Fucosiltransferasas novedosas y sus aplicaciones.
EA201691990A1 (ru) Получение библиотек вариантов белков, экспрессированных в эукариотических клетках, и применение их для отбора связывающих молекул
JP2017169582A5 (enExample)
MX2020002674A (es) Produccion de xilitol a partir de glucosa mediante una cepa recombinante.
EA201791343A1 (ru) Композиции и способы для конструирования вирусного генома in vitro
JP2014000092A5 (enExample)
HK1207111A1 (en) Methods and compositions for controlling gene expression by rna processing
MX357484B (es) Cepa con deficit de amilasa.
MX346663B (es) Lineas de celulas de bajo nivel de fucosa y usos de las mismas.
MY182355A (en) Hmo synthesis
MY185246A (en) Optimized method for producing methacrolein
Obuchowski et al. Duplicate divergence of two bacterial small heat shock proteins reduces the demand for Hsp70 in refolding of substrates
MX2024013590A (es) Adnc del antagonista del receptor de interleucina-1
WO2015199387A3 (ko) 가용성 단백질 발현량 및 활성이 증대된 헬리코박터 파일로리 유래 α-1,3 푸코실 전달효소의 유전자와 단백질 및 α-1,3 푸코실올리고당 생산에의 응용
BR112016020517A2 (pt) método de produção de lipídeo através da utilização de ss-cetoacil-acp sintase
IN2015DN03206A (enExample)
BR112012033701A2 (pt) polipeptídeo tendo atividade de degradação de carbohidrato e seus usos